Advertisement
Advertisement

ESLA

ESLA logo

Estrella Immunopharma, Inc. Common Stock

1.26
USD
Sponsored
-0.01
-0.79%
May 08, 15:43 UTC -4
Closed
exchange

After-Market

1.21

-0.05
-3.97%

Estrella Immunopharma, Inc. Common Stock Profile

About

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS(R) T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The company's lead product candidate includes EB103 and EB104. Estrella Immunopharma Inc., formerly known as TradeUP Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

Cheng Liu

Headquarters

5858 Horton Street, Suite 370
Emeryville, CA 95608, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.estrellabio.com

Auditor

Macias Gini & O�Connell LLP

Share holders

19

Employees

8

Estrella Immunopharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

51.62M

Enterprise Value

50.24M

Enterprise Value/EBITDA(ttm)

-3.85

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

260.61%

Return on Assets(ttm)

-430.91%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-13.06M

Net Income Available to Common(ttm)

-13.06M

Diluted EPS(ttm)

-0.35

Share Statistics

Beta (5Y Monthly)

0.58

52-Week Change

8.62%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

42.67M

Dividend Yield

0.00%

Float4

19.16M

% Held by Insiders

55.10%

% Held by Institutions

0.35%

Balance Sheet

Total Cash(mrq)

1.38M

Total Cash Per Share(mrq)

0.03

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.12%

Quick Ratio(mrq)

0.12%

Book Value Per Share(mrq)

-0.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.05

Free Cash Flow(ytd)

-1.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement